# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-047758
Filing Date
2025-03-31
Accepted
2025-03-31 16:18:18
Documents
81
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | tcrt-20241231.htm iXBRL | 10-K | 2391808
2 | EX-10.59 | tcrt-ex10_59.htm | EX-10.59 | 52158
3 | EX-10.60 | tcrt-ex10_60.htm | EX-10.60 | 94907
4 | EX-10.61 | tcrt-ex10_61.htm | EX-10.61 | 55146
5 | EX-10.62 | tcrt-ex10_62.htm | EX-10.62 | 85619
6 | EX-19.1 | tcrt-ex19_1.htm | EX-19.1 | 178107
7 | EX-23.1 | tcrt-ex23_1.htm | EX-23.1 | 4775
8 | EX-23.2 | tcrt-ex23_2.htm | EX-23.2 | 4687
9 | EX-31.1 | tcrt-ex31_1.htm | EX-31.1 | 15030
10 | EX-32.1 | tcrt-ex32_1.htm | EX-32.1 | 8233
11 | EX-97.1 | tcrt-ex97_1.htm | EX-97.1 | 40710
| Complete submission text file | 0000950170-25-047758.txt |  | 9776575

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | tcrt-20241231.xsd | EX-101.SCH | 1469873
83 | EXTRACTED XBRL INSTANCE DOCUMENT | tcrt-20241231_htm.xml | XML | 1368835

Mailing Address 2617 BISSONNET ST SUITE 233 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 233 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33038 | Film No.: 25793519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)